The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 6, 2012, Pages

  Fukumoto, Koichi ^a   Taniguchi, Tetsuo ^a   Ishikawa, Yoshinori ^a   Kawaguchi, Koji ^a   Fukui, Takayuki ^a   Kato, Katsuhiko ^a   Matsuo, Keitaro ^b   Yokoi, Kohei ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

18F FDG PET CT; Histologic type; Stage; Thymic epithelial tumours

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOID; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EPITHELIUM TUMOR; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; THYMOMA; THYMUS CANCER; EVALUATION; MIDDLE AGED; NEOPLASM; PATHOLOGY; SCINTISCANNING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYMOMA; THYMUS NEOPLASMS;

EID: 84873162010     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs527     Document Type: Article

References (17)

1. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. WHO Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
2. Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002;94:624-32.
3. Chen G, Marx A, Wen-Hu C, Yong J, Puppe B, Stroebel P et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002;95:420-9.
4. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol 2001;25:103-10.
5. 18F-FDG PET for the evaluation of thymic epithelial tumors: Correlation with the World Health Organization classification in addition to dual-time-point imaging. Eur J Nucl Med Mol Imaging 2009;36:1219-25.
6. Luzzi L, Capione A, Gorla A, Vassallo G, Bianchi A, Biggi A et al. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses. Eur J Cardiothorac Surg 2009;36:475-9.
7. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48: 2485-92.
8. Falkson CB, Bezjak A, Darling G, Gregg R, Malthaner R, Maziak DE et al. The management of thymoma: a systematic review and practice guideline. J Thorac Oncol 2009;4:911-9.
9. Yokoi K, Matsuguma H, Nakahara R, Kondo T, Kamiyama Y, Mori K et al. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol 2007;2:73-8.
10. Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009;361:32-9.
11. 18F] FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning. Lung Cancer 2008;61:362-8.
12. 18F] fluoro-2-deoxy D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors. Eur J Cardiothorac Surg 2011;40:143-5.
13. 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 2008;61:350-5.
14. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 2006;47:1628-34.
15. Terzi A, Bertolaccini L, Rizzardi G, Luzzi L, Bianchi A, Campione A et al. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms. Lung Cancer 2011;74:239-43.
16. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer-a PET study. J Nucl Med 1993;34:1-6.
17. Shiono S, Abiko M, Okazaki T, Chiba M, Yabuki H, Sato T. Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value. Eur J Cardiothorac Surg 2011;40:1165-9.